Disclosed herein is a compound of Formula (I) for inhibiting Bcl-xL and treating a disease associated with the undesirable Bcl-xL activity (Bcl-xL related diseases), a method of using the compounds disclosed herein for treating tumor or cancer, and a pharmaceutical composition comprising the same.
ARYL-SUBSTITUTED DIHYDROQUINOLINONES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
申请人:Neomed Institute
公开号:EP3334717B1
公开(公告)日:2020-07-01
[EN] ARYL-SUBSTITUTED DIHYDROQUINOLINONES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS<br/>[FR] DIHYDROQUINOLINONES SUBSTITUÉES PAR UN GROUPE ARYLE, LEUR PRÉPARATION ET LEUR UTILISATION COMME AGENTS PHARMACEUTIQUES
申请人:NEOMED INST
公开号:WO2017024408A1
公开(公告)日:2017-02-16
This application relates to aryl-substituted dihydroquinolinones of formula (I), compositions comprising them and their uses in the treatment of diseases and conditions in which inhibition of a bromodomain is indicated. For example, the application relates to aryl-substituted dihydroquinolinones and to their use as bromodomain inhibitors. The present application is also related to the treatment or prevention of proliferative disorders, auto-immune disorders, inflammatory disorders, dermal disorders, and neoplasms, including tumors and/or cancers.